UPDATE: JP Morgan Downgrades CNC to Neutral Heading Into Reform Implementation
March 14, 2013 at 11:09 AM EDT
In a report published by JP Morgan, analyst Michael Newshel downgraded Centene (NYSE: CNC ) from Overweight to Neutral heading into reform implementation. The price target was raised from $44.00 to $50.00. JP Morgan reported that, “Downgrading CNC on more reasonable/conservative assumptions of Medicaid expansion, reflecting slower ramp
